federal_register: 00-21937
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 00-21937 | Child-Resistant Packaging for Certain Over-The-Counter Drug Products | Proposed Rule | The Consumer Product Safety Commission (CPSC or Commission) is proposing a rule to require child-resistant (CR) packaging on drugs approved by the Food and Drug Administration (FDA) for over-the-counter (OTC) sale that contain active ingredients previously available only in prescription drugs. Current Commission regulations require CR packaging for most oral drug products containing prescription-only active ingredients. However, at present, there is no general requirement for CR packaging of such drug products in forms subsequently approved by the FDA for OTC sale. The Commission is also proposing to revoke the current prohibition on granting a petition for an exemption from a CR packaging requirement prior to FDA approval of the drug product in question. The Commission takes these actions under authority of the Poison Prevention Packaging Act of 1970, as amended. | 2000-08-30 | 2000 | 8 | https://www.federalregister.gov/documents/2000/08/30/00-21937/child-resistant-packaging-for-certain-over-the-counter-drug-products | https://www.govinfo.gov/content/pkg/FR-2000-08-30/pdf/00-21937.pdf | Consumer Product Safety Commission | 84 | The Consumer Product Safety Commission (CPSC or Commission) is proposing a rule to require child-resistant (CR) packaging on drugs approved by the Food and Drug Administration (FDA) for over-the-counter (OTC) sale that contain active ingredients... |